Trust Company of Vermont’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
231
-131
| -36% | -$58.3K | ﹤0.01% | 429 |
|
|
2025
Q1 | $176K | Sell |
362
-140
| -28% | -$67.9K | 0.01% | 355 |
|
|
2024
Q4 | $202K | Buy |
502
+106
| +27% | +$42.7K | 0.01% | 348 |
|
|
2024
Q3 | $184K | Buy |
396
+70
| +21% | +$32.6K | 0.01% | 341 |
|
|
2024
Q2 | $153K | Buy |
326
+24
| +8% | +$11.2K | 0.01% | 349 |
|
|
2024
Q1 | $126K | Sell |
302
-45
| -13% | -$18.8K | 0.01% | 360 |
|
|
2023
Q4 | $141K | Sell |
347
-12
| -3% | -$4.88K | 0.01% | 321 |
|
|
2023
Q3 | $125K | Sell |
359
-54
| -13% | -$18.8K | 0.01% | 344 |
|
|
2023
Q2 | $145K | Hold |
413
| – | – | 0.01% | 349 |
|
|
2023
Q1 | $130K | Hold |
413
| – | – | 0.01% | 366 |
|
|
2022
Q4 | $119K | Buy |
413
+300
| +265% | +$86.6K | 0.01% | 360 |
|
|
2022
Q3 | $33K | Sell |
113
-3
| -3% | -$876 | ﹤0.01% | 543 |
|
|
2022
Q2 | $33K | Buy |
+116
| New | +$33K | ﹤0.01% | 520 |
|
|
2022
Q1 | – | Sell |
-30
| Closed | -$7K | – | 734 |
|
|
2021
Q4 | $7K | Buy |
+30
| New | +$7K | ﹤0.01% | 705 |
|
|
2021
Q3 | – | Sell |
-30
| Closed | -$6K | – | 708 |
|
|
2021
Q2 | $6K | Hold |
30
| – | – | ﹤0.01% | 684 |
|
|
2021
Q1 | $6K | Hold |
30
| – | – | ﹤0.01% | 676 |
|
|
2020
Q4 | $7K | Hold |
30
| – | – | ﹤0.01% | 667 |
|
|
2020
Q3 | $8K | Hold |
30
| – | – | ﹤0.01% | 636 |
|
|
2020
Q2 | $9K | Hold |
30
| – | – | ﹤0.01% | 640 |
|
|
2020
Q1 | $7K | Hold |
30
| – | – | ﹤0.01% | 716 |
|
|
2019
Q4 | $7K | Hold |
30
| – | – | ﹤0.01% | 750 |
|
|
2019
Q3 | $5K | Hold |
30
| – | – | ﹤0.01% | 835 |
|
|
2019
Q2 | $6K | Hold |
30
| – | – | ﹤0.01% | 823 |
|
|
2019
Q1 | $6K | Sell |
30
-30
| -50% | -$6K | ﹤0.01% | 777 |
|
|
2018
Q4 | $10K | Sell |
60
-78
| -57% | -$13K | ﹤0.01% | 737 |
|
|
2018
Q3 | $27K | Hold |
138
| – | – | ﹤0.01% | 624 |
|
|
2018
Q2 | $23K | Buy |
+138
| New | +$23K | ﹤0.01% | 675 |
|